Conference sessions include:
• Convening major stakeholders
• New partnership paradigm
• Going global and going NGS: regulatory perspective
• Plenary session: Think tank on next-generation sequencing diagnostics
J. Carl Barrett, Ph.D., AstraZeneca
Catherine Brownstein, M.D., Harvard Medical School and Boston Children’s Hospital
Tracy Bush, Ph.D., Roche Diagnostics
Jennifer Dickey, RAC, Ph.D., US Food and Drug Administration
Andrea Ferreira-Gonzalez, Ph.D., Virginia Commonwealth University
Carlos Gil Ferreira, M.D., Brazilian National Cancer Institute
Eric T Fung, M.D., Ph.D., Affymetrix
Kevin M. Harter, Saladax Biomedical
Matthew J. Hawryluk, Ph.D., Foundation Medicine, Inc.
Madhuri Hegde, Ph.D., FACMG, Emory University School of Medicine
Eric Lai, Ph.D., Takeda Pharmaceuticals
Sabah Malek, Eisai, Inc.
Frank S. Ong, M.D., Illumina, Inc.
David Parker, Ph.D., Precision for Medicine
Nick Poulios, Ph.D., Roche Molecular Systems, Inc.
Mitch Raponi, Clovis Oncology
Judi Smith, Vice President,Precision for Medicine
John Quackenbush, Ph.D., GenoSpace / Dana-Farber Cancer Institute and Harvard School of Public Health
Writers and editors are invited to attend. To request a press pass, email Lisa Scimemi, firstname.lastname@example.org.
For more information, visit http://www.NextGenerationDx.com/
About Next Generation Dx Summit
Access to next generation diagnostics will only be gained through careful creation and management of partnerships in the community around development, commercialization, reimbursement and regulation. This year’s Next Generation Dx Summit will showcase advances in personalized medicine through a comprehensive program encompassing companion diagnostics, infectious disease, cancer molecular markers, point-of-care, inherited disorders, cell free DNA and single cell sequencing. This event has become the meeting place for major players in the expanding arena of diagnostics. It will showcase key components of their successful adoption in the clinic and advancement to the market. http://www.NextGenerationDx.com
About Cambridge Healthtech Institute (CHI)
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, and The Knowledge Foundation. http://www.chicorporate.com